The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
A phase I/II study of first-in-human trial of JAB-21822 (KRAS G12C inhibitor) in advanced solid tumors.
 
Jian Li
No Relationships to Disclose
 
Jun Zhao
No Relationships to Disclose
 
Baoshan Cao
No Relationships to Disclose
 
Jian Fang
Consulting or Advisory Role - Hansoh Pharma
Research Funding - Hansoh Pharma (Inst)
 
Xiaoyan Li
No Relationships to Disclose
 
Mengzhao Wang
No Relationships to Disclose
 
Yi Ba
No Relationships to Disclose
 
Xingya Li
No Relationships to Disclose
 
Zhihua Li
No Relationships to Disclose
 
Zhe LIU
No Relationships to Disclose
 
Yongsheng Wang
No Relationships to Disclose
 
Ying Cheng
No Relationships to Disclose
 
Chunmei Bai
No Relationships to Disclose
 
Lin Shen
Consulting or Advisory Role - AstraZeneca; Bristol-Myers Squib; Daiichi Sankyo; Harbour BioMed; Merck; Mingji biopharmaceutical; MSD; Roche
Speakers' Bureau - Hutchison Whampoa; MSD
Research Funding - Baiji Shenzhou (Beijing) Biotechnology (Inst); Beijing Xiantong Biomedical Technology (Inst); Nanjing Yaojieankang Biotechnology (Inst); QiLu Pharmaceutical (Inst); Zaiding Pharmaceutical (Inst)